| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2081002 | Drug Discovery Today | 2006 | 7 Pages |
Abstract
From a direct comparison of the technical benefits of labelled reporter assays with the benefits of label-free assays, label-free appears to have significant advantages. Faster assay development times; accurate, high information content data; and less interference from labels. However, optical label-free platforms have not yet made a major impact in the drug discovery technology markets; are often viewed as having poor throughput, limited application; and are difficult to learn and use effectively.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Matthew A. Cooper,